These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19524591)

  • 1. Extracellular matrix remodeling during the progression of volume overload-induced heart failure.
    Hutchinson KR; Stewart JA; Lucchesi PA
    J Mol Cell Cardiol; 2010 Mar; 48(3):564-9. PubMed ID: 19524591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.
    Moore L; Fan D; Basu R; Kandalam V; Kassiri Z
    Heart Fail Rev; 2012 Sep; 17(4-5):693-706. PubMed ID: 21717224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.
    Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL
    Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
    Frangogiannis NG
    Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure.
    Hutchinson KR; Guggilam A; Cismowski MJ; Galantowicz ML; West TA; Stewart JA; Zhang X; Lord KC; Lucchesi PA
    J Appl Physiol (1985); 2011 Dec; 111(6):1778-88. PubMed ID: 21885799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated Lagrangian constrained mixture model of pathological cardiac growth and remodelling.
    Guan D; Zhuan X; Luo X; Gao H
    Acta Biomater; 2023 Aug; 166():375-399. PubMed ID: 37201740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Krebber MM; van Dijk CGM; Vernooij RWM; Brandt MM; Emter CA; Rau CD; Fledderus JO; Duncker DJ; Verhaar MC; Cheng C; Joles JA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
    Voloshenyuk TG; Gardner JD
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.
    El Hajj EC; El Hajj MC; Ninh VK; Gardner JD
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H463-H473. PubMed ID: 29775412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension.
    Takenaka H; Kihara Y; Iwanaga Y; Onozawa Y; Toyokuni S; Kita T
    J Mol Cell Cardiol; 2006 Dec; 41(6):989-97. PubMed ID: 16979182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG; Coker ML; Bond BR; Zellner JL
    Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
    Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
    Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A look between the cardiomyocytes: the extracellular matrix in heart failure.
    Miner EC; Miller WL
    Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-associated matrix proteolysis and heart failure.
    Spinale FG; Janicki JS; Zile MR
    Circ Res; 2013 Jan; 112(1):195-208. PubMed ID: 23287455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats.
    Murray DB; Gardner JD; Brower GL; Janicki JS
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1251-7. PubMed ID: 18178727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial extracellular matrix remodeling in ischemic heart failure.
    Gallagher GL; Jackson CJ; Hunyor SN
    Front Biosci; 2007 Jan; 12():1410-9. PubMed ID: 17127391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP induction and inhibition in myocardial infarction.
    Lindsey ML
    Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.
    Janicki JS; Brower GL; Gardner JD; Chancey AL; Stewart JA
    Heart Fail Rev; 2004 Jan; 9(1):33-42. PubMed ID: 14739766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases: pathways of induction by bioactive molecules.
    Tsuruda T; Costello-Boerrigter LC; Burnett JC
    Heart Fail Rev; 2004 Jan; 9(1):53-61. PubMed ID: 14739768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.